Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma

Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma

Zhongren Zhou,1 Irina Kalatskaya,2 Donna Russell,1 Norman Marcon,3 Maria Cirocco,3 Paul M Krzyzanowski,2 Cathy Streutker,3 Hua Liang,4 Virginia R Litle,5 Tony E Godfrey,5 Lincoln Stein21Department of Pathology & Immunology, Washington University, Saint Louis, MO, USA; 2Department of Adaptive...

Full description

Bibliographic Details
Main Authors: Zhou Z, Kalatskaya I, Russell D, Marcon N, Cirocco M, Krzyzanowski PM, Streutker C, Liang H, Litle VR, Godfrey TE, Stein L
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Clinical and Experimental Gastroenterology
Subjects:
Barrett’s esophagus
esophageal adenocarcinoma
Cytology screening
MUC2 IHC
EsophaCap
intestinal metaplasia
Online Access:https://www.dovepress.com/combined-esophacap-cytology-and-muc2-immunohistochemistry-for-screenin-peer-reviewed-article-CEG

Internet

https://www.dovepress.com/combined-esophacap-cytology-and-muc2-immunohistochemistry-for-screenin-peer-reviewed-article-CEG

Similar Items